Amyotrophic lateral sclerosis (ALS) exhibit heterogeneous functional decline, potentially influenced by systemic metabolic reserve. We investigate whether circulating insulin-like growth factor 1 (IGF-1) is associated with subsequent functional change in ALS. Serum IGF-1 was measured in 37 participants with ALS and 25 healthy controls.
Circulating insulin-like growth factor 1 (IGF-1) and short-term functional change in amyotrophic lateral sclerosis (ALS): exploratory evidence for systemic trophic-metabolic reserve.
calendar_today
November 6, 2026
person
Lim, C. K., Brocardo, M., Hunter, J., Heads, J. A., Rowe, D. B., Furlong, S., Atkin, J. D.
domain
medrxiv